Form 4 for GLUE Monte Rosa Therapeutics, Inc.
Accepted 2026-06-25 16:05:04 ET · period of report 2026-06-23 · accession 0001193125-26-282735 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-06-25 16:05 | 2026-06-23 | GLUE | Champoux Jennifer | COO | M - OptEx | $3.98 | +2,175 | 64.5K | +3% | +$8,656 |
| DT | 2026-06-25 16:05 | 2026-06-23 | GLUE | Champoux Jennifer | COO | S - Sale+OE | $20.00 | -2,175 | 62.4K | -3% | -$43.5K |
| DT | 2026-06-25 16:05 | 2026-06-23 | GLUE | Champoux Jennifer | COO | M - OptEx | $0.00 | -2,175 | 31.3K | -6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-23 | M | A | 2,175 | $3.98 | 64,546 | D | — | — | (F1) These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 19, 2026. |
| 2 | Common | Common Stock | 2026-06-23 | S | D | 2,175 | $20.00 | 62,371 | D | — | — | (F1) These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 19, 2026. |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-06-23 | M | D | 2,175 | $0.00 | 31,298 | D | $3.98 · — to 2034-06-03 | 2,175 Common Stock | (F1) These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 19, 2026. (F2) 25% of this option vested on May 28, 2025, with the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. |